Fighting Alzeimer's disease: Hong Kong's Science and Technology Parks

Hong Kong’s start-up scene is combining innovation and entrepreneurial spirit with universities and laboratories, coupled with the industrial might of the Greater Bay Area.

At Hong Kong’s Science and Technology Parks, research clusters called InnoHK are developing global collaboration. Health@InnoHK focuses on healthcare and AIR@InnoHK on AI and robotics technologies. Science Park is currently working in collaboration with the University College of London and Stanford University. 

Nancy Ip, is the Director of Hong Kong Centre for Neurodegenerative Diseases  explains what this collaborative effort works.

“The Hong Kong Science Park has provided the much-needed infrastructure for innovation in technology development. And these biotech start-ups, they they can achieve a lot of synergy by interacting with each other in Science Park.

One project that we collaborate on is developing a blood-based biomarker test for Alzheimer's disease. So this is a very exciting project for us because it really illustrates the power of collaboration amongst the three institutions. With the ageing population worldwide, neurodegenerative diseases, given that it is age related diseases, the prevalence has been increasing substantially.”

AIR@InnoHK, works with people such as Helen Meng at the Centre for Perceptual and Interactive Intelligence, part of the Chinese University of Hong Kong. They work with MIT and others in developing wearable electronics, as Helen Meng explains.

“They can use it for rehabilitation, or we can also use it in sports, in sports training for athletes where the sensors that are embedded in the garment can be used to measure the motions of the athlete in training.”

One of the companies that’s part of that ecosystem is the French